Cargando…
Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action
In November 2013, a team of European regulators initiated the Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) Joint Action. Funded by the Health Programme of the European Union, and with contributions from the involved Member States, SCOPE gathered information and exper...
Autores principales: | Radecka, Anna, Loughlin, Louise, Foy, Mick, de Ferraz Guimaraes, Margarida Viana, Sarinic, Viola Macolic, Di Giusti, Marina Dimov, Lesicar, Marina, Straus, Sabine, Montero, Dolores, Pallos, Julia, Ivanovic, Jelena, Raine, June |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223699/ https://www.ncbi.nlm.nih.gov/pubmed/30128638 http://dx.doi.org/10.1007/s40264-018-0708-5 |
Ejemplares similares
-
Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study
por: Mirošević Skvrce, Nikica, et al.
Publicado: (2011) -
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
por: Francescon, Sara, et al.
Publicado: (2018) -
Classification of Recombinant Biologics in the EU: Divergence Between National Pharmacovigilance Centers
por: Klein, Kevin, et al.
Publicado: (2015) -
Smart Safety Surveillance (3S): Multi-Country Experience of Implementing the 3S Concepts and Principles
por: Iessa, Noha, et al.
Publicado: (2021) -
Practical applications of regulatory requirements for signal
detection and communications in pharmacovigilance
por: Malikova, Marina A.
Publicado: (2020)